First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Stock Price Down 2.4%

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)’s share price traded down 2.4% on Friday . The company traded as low as $23.34 and last traded at $23.34, 500 shares changed hands during mid-day trading. A decline of 77% from the average session volume of 2,136 shares. The stock had previously closed at $23.92.

The stock has a fifty day moving average of $23.43 and a two-hundred day moving average of $21.42.

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 31st. Investors of record on Monday, December 16th were issued a $0.0411 dividend. The ex-dividend date of this dividend was Friday, December 13th. This represents a $0.16 dividend on an annualized basis and a yield of 0.70%. This is a boost from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.04.

An institutional investor recently bought a new position in First Trust Nasdaq Pharmaceuticals ETF stock. LPL Financial LLC bought a new stake in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 15,466 shares of the company’s stock, valued at approximately $327,000. LPL Financial LLC owned about 4.42% of First Trust Nasdaq Pharmaceuticals ETF at the end of the most recent quarter.

Recommended Story: Why are gap-down stocks important?

Receive News & Ratings for First Trust Nasdaq Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust Nasdaq Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.